Information may be obtained or stored in your browser by cookies when you access the Website. This information is related to the user, the user settings or device. It is primarily used to ensure the site functions as expected by the user. We respect your right to privacy. Therefore, you can select to not allow some types of cookie. Please click on the different category headings to check the details and then change our default settings.
Strictly Necessary Cookies are cookies that are essential for this site to function properly. Strictly Necessary Cookies do not store information that can identify individuals. Strictly Necessary Cookies are used to view this site. Therefore, you cannot refuse the use of Strictly Necessary Cookies from these cookie settings. However, you can refuse the use of Strictly Necessary Cookies from the settings of your browser at any time. Please note that parts of the site may not function if you refuse the use of Strictly Necessary Cookies.
This site uses the following Strictly Necessary Cookies.
Cookie name: gdprCookieEn
Cookie name: optGA
Cookie name: optPardot
Nippon Kayaku provides diagnostics pertaining to tumor markers, which are useful for diagnosing cancer and judging the therapeutic effects and prognosesin the pharmaceuticals business.
Nippon Kayaku also produces and sells blood sugar control markers (GlycoMark) used for diabetes. This product has been approved by the U.S. Food and Drug Administration (FDA) and are used in foreign countries. Nippon Kayaku has been deploying its business all over the world.